Biolife Solutions Inc Asset Turnover Ratio (BLFS), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biolife Solutions Inc   (NASDAQ: BLFS)
 

Biolife Solutions Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Biolife Solutions Inc asset turnover ratio, the ability of Biolife Solutions Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.25 in the first quarter (Mar 31 2026), yet the ratio remained below the average, as BLFS's position remain challenging.

Within sector 28 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 732 to 984.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLFS Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 1.46 % 4.59 % 7.27 % 6.45 % 1.85 %
Y / Y Revenue Change 14.85 % - -8.19 % -10.26 % -24.54 %
Asset Turnover Ratio (TTM) 0.25 0.24 0.19 0.2 0.21
BLFS's Total Ranking # 984 # 732 # 0 # 0 # 0
Seq. Asset Change -1.23 % 3.52 % 1.25 % -2 % 1.82 %
Seq. Revenue Change 47.12 % -33.41 % 10.41 % 6.18 % -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 29
Healthcare Sector # 110
Overall Market # 984

Asset Turnover Ratio Statistics
High Average Low
15.64 7.67 5.1
(Sep. 30, 2013)   (Mar 31 2023)




BLFS Company Profile • Back to BLFS Efficiency Comparisons • Compare BLFS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Jaguar Health Inc   0.68 $ 29.569  Millions$ 43.374  Millions
Sight Sciences Inc   0.68 $ 78.550  Millions$ 115.807  Millions
Avanos Medical Inc   0.68 $ 714.200  Millions$ 1,057.625  Millions
Strata Critical Medical Inc   0.67 $ 209.937  Millions$ 311.522  Millions
3m Company  0.67 $ 25,024.000  Millions$ 37,192.250  Millions
Anaptysbio Inc   0.67 $ 232.388  Millions$ 345.607  Millions
Establishment Labs Holdings Inc   0.66 $ 228.835  Millions$ 344.192  Millions
Guardant Health Inc   0.66 $ 1,080.215  Millions$ 1,634.434  Millions
U S Physical Therapy Inc  0.66 $ 795.488  Millions$ 1,205.484  Millions
Resmed Inc   0.66 $ 5,504.590  Millions$ 8,360.355  Millions
Urogen Pharma Ltd   0.66 $ 139.526  Millions$ 211.977  Millions
Ani Pharmaceuticals Inc  0.66 $ 923.706  Millions$ 1,403.375  Millions
Dentsply Sirona Inc   0.66 $ 3,681.000  Millions$ 5,595.000  Millions
Pulmonx Corporation  0.66 $ 87.841  Millions$ 133.681  Millions
Align Technology inc   0.66 $ 4,094.492  Millions$ 6,250.128  Millions
Allurion Technologies Inc   0.65 $ 12.357  Millions$ 19.019  Millions
Eli Lilly And Company  0.65 $ 72,249.500  Millions$ 111,227.500  Millions
Tg Therapeutics Inc   0.65 $ 700.349  Millions$ 1,079.932  Millions
Immucell Corporation  0.65 $ 29.035  Millions$ 44.773  Millions
Staar Surgical Co  0.65 $ 290.375  Millions$ 449.235  Millions
Bioaffinity Technologies Inc   0.64 $ 5.660  Millions$ 8.801  Millions
Novocure Limited  0.64 $ 674.414  Millions$ 1,049.830  Millions
Akebia Therapeutics Inc   0.64 $ 232.404  Millions$ 362.208  Millions
Stereotaxis Inc   0.64 $ 30.801  Millions$ 48.260  Millions
Sarepta Therapeutics Inc   0.64 $ 2,184.184  Millions$ 3,425.472  Millions
Halozyme Therapeutics Inc   0.64 $ 1,508.458  Millions$ 2,368.293  Millions
Procept Biorobotics Corporation  0.64 $ 321.012  Millions$ 504.934  Millions
Ss Innovations International Inc  0.63 $ 48.259  Millions$ 76.082  Millions
Macrogenics Inc   0.63 $ 157.083  Millions$ 247.724  Millions
Zoetis Inc   0.63 $ 9,509.000  Millions$ 15,064.750  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.